Rekombinanter MED12 Antikörper (AA 2127-2177)
Kurzübersicht für Rekombinanter MED12 Antikörper (AA 2127-2177) (ABIN7453977)
Target
Alle MED12 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 2127-2177
-
Verwendungszweck
- Rabbit anti-MED12 Recombinant Monoclonal Antibody [BLR084G]
-
Immunogen
- between AA 2127 and 2177 (C-term)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1000 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- MED12 (Mediator Complex Subunit 12 (MED12))
-
Andere Bezeichnung
- MED12
-
Hintergrund
- Background: MED12 is a component of the multisubunit mediator complex that functions as an interface between gene-specific transcription factors and the RNA Pol II/general transcription factor machinery. The mediator complex was first identified as a coactivator of the thyroid hormone receptor and has since been observed to function as a coactivator of a variety of transcription factors. In this context, MED12 interaction with beta-catenin has been shown to be required for Wnt-signaling dependent transcription.
-
Gen-ID
- 9968
-
NCBI Accession
- NP_005111
-
UniProt
- Q93074
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Stem Cell Maintenance, Chromatin Binding, Regulation of Lipid Metabolism by PPARalpha, Tube Formation
Target
-